GT Biopharma, Inc.
NASDAQGTBP short interest surged 36% over one week to 7.86% of float, then fell 13% in a single day as cost to borrow eased to 9.47%.
Snapshot as of 25 Jun 2026
GT Biopharma heads into its May 15 earnings report with short sellers stepping up pressure on a stock already down more than half its value this year. Short interest is the defining story here. It jumped 43% in a…
Short interest in GT Biopharma has collapsed 54% over the past month while cost to borrow plunged 65%. Despite easing short pressure, shares fell 18% this week to $0.31. GTBP closed at $0.31 on April 24, down 13% on…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for GTBP — free to start on ORTEX.
Sign up for free →Open GTBP on ORTEX